5Frank O, Rudolph C, Heberlein C, et al. Tumor cells escape suicide gene therapy by genetic and epigenetic instability [J].Blood ,2004, 104(12) :3543.
6Dummer R, Hassel JC, Fellenberg F, et al. Adenovirus-mediated intralesional interferon-( gene transfer induces tumor regressions in cutaneous lymphomas [J]. Blood , 2004 ,104 (6) : 1631.
7Trieu Y, Wen XY, Skinnider BF, et al. Soluble Interleukin-13R ( 2 Decoy Receptor Inhibits Hodgkin' s Lymphoma Growth in Vitro and in Vivo [J]. Cancer Res,2004,64(9) :3271.
8MAttOM, Nuutinen UM, Hakkarainen T, et al. hCAR-EGFP fusion receptor in human follicular lymphoma B cells - a model for adenoviral gene therapy for B cell malignancies[J]. Int J Mol Med, 2006,17 (6) :1057.
9Urosevic M,Fujii K,Calmels B,et al. Type I IFN innate immune response to adenovirus-mediated IFN-γ gene transfer contributes to the regression of cutaneous lymphomas [J]. J Clin Invest, 2007, 117 (10) :2834.
10Urosevie M. Drug evaluation : TG-1042, an adenovirus-mediated IFN- gamma gene delivery for the intratumoral therapy of primary cutaneous lymphomas [ J 3. Curr Opin Investig Druqs, 2007,8 ( 6 ) :493.
